Empagliflozin/Sitagliptin Hydrochloride
恩格列净/盐酸西格列汀
Report date: 2025/09/09 20:00:05
Base Information
Drug NameEmpagliflozin/Sitagliptin Hydrochloride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes EmpagliflozinSitagliptin Hydrochloride
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewon Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesDaewon Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A